MedTrace Logo

HIDRAdenitis Suppurativa and HEART Disease

NCT05989945 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-08-01

No results posted yet for this study

Summary

In a prospective observational cohort study (n = 250) the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and HS severity and determine whether these are prognostic markers of heart disease in patients suffering from hidradenitis suppurativa (HS).

Conditions

Sponsors & Collaborators

  • Herlev and Gentofte Hospital

    lead OTHER

Principal Investigators

  • Tor Biering-Sørensen, MD PhD MPH · Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen

  • Claus Zachariae, MD DMSc · Department of Dermato-Allergology, Herlev and Gentofte University Hospital, University of Copenhagen

  • Lone Skov, MD PhD DMSc · Department of Dermato-Allergology, Herlev and Gentofte University Hospital, University of Copenhagen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2025-01-06
Completion
2033-08-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05989945 on ClinicalTrials.gov